Literature DB >> 31857391

Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma.

Tomohiro Aoki1,2, Lauren C Chong1, Katsuyoshi Takata1, Katy Milne3,4, Monirath Hav5, Anthony Colombo5, Elizabeth A Chavez1, Michael Nissen6, Xuehai Wang6, Tomoko Miyata-Takata1, Vivian Lam6, Elena Viganò1,2, Bruce W Woolcock1, Adèle Telenius1, Michael Y Li1,2, Shannon Healy1, Chanel Ghesquiere3,4, Daniel Kos3,4, Talia Goodyear3,4, Johanna Veldman7, Allen W Zhang8,9, Jubin Kim6, Saeed Saberi8, Jiarui Ding8,10, Pedro Farinha1, Andrew P Weng6, Kerry J Savage1, David W Scott1, Gerald Krystal6, Brad H Nelson3,4,11, Anja Mottok1,12, Akil Merchant5, Sohrab P Shah2,8,9, Christian Steidl13,2.   

Abstract

Hodgkin lymphoma is characterized by an extensively dominant tumor microenvironment (TME) composed of different types of noncancerous immune cells with rare malignant cells. Characterization of the cellular components and their spatial relationship is crucial to understanding cross-talk and therapeutic targeting in the TME. We performed single-cell RNA sequencing of more than 127,000 cells from 22 Hodgkin lymphoma tissue specimens and 5 reactive lymph nodes, profiling for the first time the phenotype of the Hodgkin lymphoma-specific immune microenvironment at single-cell resolution. Single-cell expression profiling identified a novel Hodgkin lymphoma-associated subset of T cells with prominent expression of the inhibitory receptor LAG3, and functional analyses established this LAG3+ T-cell population as a mediator of immunosuppression. Multiplexed spatial assessment of immune cells in the microenvironment also revealed increased LAG3+ T cells in the direct vicinity of MHC class II-deficient tumor cells. Our findings provide novel insights into TME biology and suggest new approaches to immune-checkpoint targeting in Hodgkin lymphoma. SIGNIFICANCE: We provide detailed functional and spatial characteristics of immune cells in classic Hodgkin lymphoma at single-cell resolution. Specifically, we identified a regulatory T-cell-like immunosuppressive subset of LAG3+ T cells contributing to the immune-escape phenotype. Our insights aid in the development of novel biomarkers and combination treatment strategies targeting immune checkpoints.See related commentary by Fisher and Oh, p. 342.This article is highlighted in the In This Issue feature, p. 327. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2019        PMID: 31857391     DOI: 10.1158/2159-8290.CD-19-0680

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  54 in total

Review 1.  Hodgkin lymphoma.

Authors:  Joseph M Connors; Wendy Cozen; Christian Steidl; Antonino Carbone; Richard T Hoppe; Hans-Henning Flechtner; Nancy L Bartlett
Journal:  Nat Rev Dis Primers       Date:  2020-07-23       Impact factor: 52.329

2.  Fundamentals of immunology for understanding immunotherapy for lymphoma.

Authors:  Stephen M Ansell
Journal:  Blood Adv       Date:  2020-11-24

Review 3.  Fundamentals of immunology for understanding immunotherapy for lymphoma.

Authors:  Stephen M Ansell
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

4.  The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma.

Authors:  Joji Nagasaki; Yosuke Togashi; Takeaki Sugawara; Makiko Itami; Nobuhiko Yamauchi; Junichiro Yuda; Masato Sugano; Yuuki Ohara; Yosuke Minami; Hirohisa Nakamae; Masayuki Hino; Masahiro Takeuchi; Hiroyoshi Nishikawa
Journal:  Blood Adv       Date:  2020-09-08

Review 5.  [Microenvironment in classical Hodgkin lymphoma].

Authors:  Anja Mottok
Journal:  Pathologe       Date:  2020-05       Impact factor: 1.011

6.  LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma.

Authors:  Colm Keane; Soi C Law; Clare Gould; Simone Birch; Muhammed B Sabdia; Lilia Merida de Long; Gayathri Thillaiyampalam; Emad Abro; Joshua W Tobin; Xiaohong Tan; Zijun Y Xu-Monette; Ken H Young; Grace Gifford; Sara Gabreilli; William S Stevenson; Anthony Gill; Dipti Talaulikar; Sanjiv Jain; Annette Hernandez; Sarah-Jane Halliday; Robert Bird; Donna Cross; Mark Hertzberg; Maher K Gandhi
Journal:  Blood Adv       Date:  2020-04-14

Review 7.  AYA Considerations for Aggressive Lymphomas.

Authors:  Gabriela Llaurador; Lisa Giulino-Roth
Journal:  Curr Hematol Malig Rep       Date:  2021-03-16       Impact factor: 3.952

8.  Significance of single-cell and spatial transcriptomes in cell biology and toxicology.

Authors:  Duojiao Wu; Xiaozhuan Liu; Jiaqiang Zhang; Li Li; Xiangdong Wang
Journal:  Cell Biol Toxicol       Date:  2021-01-04       Impact factor: 6.691

9.  Analysis of Autophagy-Related Signatures Identified Two Distinct Subtypes for Evaluating the Tumor Immune Microenvironment and Predicting Prognosis in Ovarian Cancer.

Authors:  Xingyu Chen; Hua Lan; Dong He; Zhanwang Wang; Runshi Xu; Jing Yuan; Mengqing Xiao; Yao Zhang; Lian Gong; Songshu Xiao; Ke Cao
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

10.  Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma.

Authors:  Gabriel K Griffin; Jason L Weirather; Margaretha G M Roemer; Mikel Lipschitz; Alyssa Kelley; Pei-Hsuan Chen; Daniel Gusenleitner; Erin Jeter; Christine Pak; Evisa Gjini; Bjoern Chapuy; Michael H Rosenthal; Jie Xu; Benjamin J Chen; Aliyah R Sohani; Scott B Lovitch; Jeremy S Abramson; Jeffrey J Ishizuka; Austin I Kim; Caron A Jacobson; Ann S LaCasce; Christopher D Fletcher; Donna Neuberg; Gordon J Freeman; F Stephen Hodi; Kyle Wright; Azra H Ligon; Eric D Jacobsen; Philippe Armand; Margaret A Shipp; Scott J Rodig
Journal:  Blood       Date:  2021-03-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.